Emergence of Staphylococcus aureus (MRSA) with reduced susceptibility to teicoplanin during therapy

J Antimicrob Chemother. 2002 Aug;50(2):306-7. doi: 10.1093/jac/dkf110.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Drug Resistance, Bacterial / physiology
  • Humans
  • Methicillin Resistance / physiology*
  • Staphylococcus aureus / drug effects*
  • Staphylococcus aureus / isolation & purification
  • Staphylococcus aureus / physiology
  • Teicoplanin / administration & dosage
  • Teicoplanin / pharmacology*
  • Teicoplanin / therapeutic use*

Substances

  • Teicoplanin